about
Severe falciparum malaria. World Health Organization, Communicable Diseases ClusterEvaluation of hydroxychloroquine retinopathy with multifocal electroretinography.Drug toxicity.Continuation of long term treatment with hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis.Effects of pyrimethamine versus proguanil in malarial chemoprophylaxis in children with sickle cell disease: a randomized, placebo-controlled, open-label study.Ocular toxicity of chloroquine among Thai patients.Relative sensitivity and specificity of 10-2 visual fields, multifocal electroretinography, and spectral domain optical coherence tomography in detecting hydroxychloroquine and chloroquine retinopathy.A comparison of structural and functional changes in patients screened for hydroxychloroquine retinopathy.Treatment of cutaneous lupus erythematosus.Detecting chloroquine retinopathy: electro-oculogram versus colour visionHumphrey visual field findings in hydroxychloroquine toxicityOcular manifestations of systemic lupus erythematosus: a clinical review.Multifocal electroretinography after high dose chloroquine therapy for malaria.Hydrochloroquine retinopathy: characteristic presentation with review of screening.Familial interstitial lung disease in children: response to chloroquine treatment in one sibling with desquamative interstitial pneumonitis.Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation.Factors associated with chloroquine-induced retinopathy in rheumatic diseases.A comparative study of the usefulness of color vision, photostress recovery time, and visual evoked potential tests in early detection of ocular toxicity from hydroxychloroquine.Retinal disorders in northern Brazilian patients treated with chloroquine assessed by multifocal ERG.Ocular toxicity of antimalarials in dermatology: a survey of current practice.Retinopathy due to antimalarial drugs in patients with connective tissue diseases: are they so innocent? A single center retrospective study.Hydroxychloroquine, dosage parameters and retinopathy.Chronic Graft-Versus-Host Disease in Children
P2860
Q29614923-CDF0CA9E-0C64-4619-84CA-DD94D27A0107Q31142694-46A70C8E-5CE9-4E64-86C2-45438B8B3564Q33562630-F77735AB-E393-4812-BB26-D794D4BD62E6Q33565136-91B288B5-DABC-4B83-A387-5FE8A6C6E1A6Q33739065-B244BF0D-0C28-4006-9360-0DAC8F3CEF3DQ33815798-E28D5985-5F46-47B5-AC70-7DE74104E83AQ34005507-4878C145-F912-460E-A6F7-5DA55184F18AQ35001994-E5E0B8C0-D473-46F7-ACBA-1B08E340ECD2Q35222834-7114B8CF-14B1-48F8-A54D-F15D1361997CQ35591207-3909336B-F0AC-469F-B82D-9164E27AAFACQ35603566-40DD77CE-4D44-44D3-BEC4-DB0E6F5FBFF7Q36398299-CC8201DC-9B52-4035-8A4A-6DFBDAE8EE10Q37369932-A1349845-2ECC-42E2-9459-34F9BD6982ABQ38091637-5BF97962-1EF9-404A-8FD5-312E2CC83E23Q41350350-D0BC9C2E-74F4-4542-9428-1C66F0FCC3AFQ41914191-423158F6-E5A9-4EA0-9A58-B2813A1AEF63Q41914430-5F434103-C0CB-465F-8EC9-583C2987AB10Q41932265-50B72AF3-646A-40AA-8885-9735712CDA98Q41933717-F9B9C23D-1442-4876-95AB-A5B97A0E0B95Q41934252-4DF7BB7F-AEA6-44E2-BAE4-35DAB37188ADQ41935248-1D79A3BF-3B8A-410B-8F7B-BE6C49E077ACQ41936605-CEB11F8C-5EB5-49E2-9981-28DF6A0B81DCQ59094154-33119CFF-206C-4AFE-9191-63F3B533B668
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Ocular effects and safety of antimalarial agents.
@en
type
label
Ocular effects and safety of antimalarial agents.
@en
prefLabel
Ocular effects and safety of antimalarial agents.
@en
P1476
Ocular effects and safety of antimalarial agents.
@en
P2093
M Easterbrook
P356
10.1016/0002-9343(88)90358-0
P407
P577
1988-10-01T00:00:00Z